TABLE 2

Tissue Distribution Ratios After Coinjection in Mice of 211At-Trastuzumab Labeled by Direct Procedure and 125I-Trastuzumab Labeled by Conventional Procedure

Tissue distribution ratio* at:
Tissue1 h3 h6 h11 h24 h
Blood0.98 ± 0.040.97 ± 0.020.96 ± 0.030.94 ± 0.020.89 ± 0.02
Neck1.10 ± 0.041.18 ± 0.051.50 ± 0.151.15 ± 0.131.44 ± 0.21
Salivary gland1.17 ± 0.041.29 ± 0.051.30 ± 0.031.25 ± 0.121.28 ± 0.13
Heart1.06 ± 0.041.08 ± 0.031.06 ± 0.020.99 ± 0.020.97 ± 0.02
Lung1.11 ± 0.051.14 ± 0.021.19 ± 0.061.09 ± 0.051.03 ± 0.08
Liver1.03 ± 0.030.90 ± 0.090.95 ± 0.040.92 ± 0.080.78 ± 0.05
Stomach1.29 ± 0.081.72 ± 0.072.36 ± 0.302.84 ± 0.661.88 ± 0.52
Small intestine1.05 ± 0.051.03 ± 0.031.09 ± 0.061.03 ± 0.020.93 ± 0.09
Large intestine1.06 ± 0.081.09 ± 0.021.13 ± 0.050.93 ± 0.030.93 ± 0.03
Kidney1.00 ± 0.051.07 ± 0.011.09 ± 0.021.04 ± 0.010.98 ± 0.03
Muscle1.05 ± 0.021.09 ± 0.021.09 ± 0.030.89 ± 0.080.87 ± 0.05
Spleen1.03 ± 0.101.02 ± 0.111.13 ± 0.121.02 ± 0.060.83 ± 0.06
  • * Results are given as mean ± SD (%IA/g for 211At/%IA/g for 125I) for 4 animals at each time point.